InSpan Procedure: Decompression, Fusion & Recovery | Dr. Amit Sharma

InSpan may be considered for selected patients with lumbar spinal stenosis, degenerative disc disease, or spondylolisthesis when decompression and stabilization are both being evaluated.

At SpinePain Solutions, the important advantage is not simply the name of the implant. The posterior approach permits us to inspect the operative level and, when needed, remove selected portions of hypertrophied ligamentum flavum or bone that are directly compressing the nerves. InSpan is then used as one component of the stabilization and bone-graft-supported fusion plan.

What Is the InSpan Procedure?

InSpan is a titanium spinous-process plate system placed through a posterior midline approach. Opposing plates engage the spinous processes, and locking components secure the construct. The system is supplied in different dimensions so the implant can be matched to the patient’s anatomy.

The FDA-cleared labeling describes InSpan as a posterior non-pedicle supplemental fixation system for the non-cervical spine from T1 through S1. The stated indications include spondylolisthesis, trauma, tumor, degenerative disc disease, and lumbar spinal stenosis. The labeling also states that it is intended for use with bone-graft material and is not intended for stand-alone use.

Regulatory indications are not automatic treatment recommendations. A patient with stenosis on MRI may need no operation, decompression alone, decompression with a fusion construct, or a different procedure entirely.

Why Direct Decompression Matters

Lumbar stenosis is often produced by more than one structure. A thickened ligamentum flavum may buckle into the spinal canal. Enlarged facet joints or laminar bone may narrow the central canal, lateral recess, or neural foramen.

When fixed tissue is directly compressing a nerve, relying only on distraction may be insufficient. Through the posterior InSpan approach, the surgeon can perform a focused decompression before completing stabilization. Depending on the anatomy, this may include:

• Removal of selected portions of hypertrophied ligamentum flavum
• Limited laminotomy
• Lateral-recess decompression
• Foraminotomy
• Limited medial facetectomy when necessary

The amount of tissue removed must be individualized. Excessive decompression can destabilize the segment, while inadequate decompression can leave persistent nerve compression.

InSpan Is Not the Same as an Interspinous Spacer

The location between the spinous processes causes several different device categories to be confused with one another.

Why We Always Use Bone Graft With InSpan

At SpinePain Solutions, every InSpan procedure includes bone graft. This is not an optional add-on in our technique. It is part of the fusion procedure and is consistent with the device labeling.

Fixation and fusion are related but different processes. The implant supplies immediate mechanical support. Bone graft provides the biologic material intended to support bone formation across the prepared fusion area.

Fusion is not immediate. The process develops over months and depends on multiple factors, including:

• Bone quality and local anatomy
• Construct stability and surgical preparation
• Nicotine exposure
• Diabetes control
• Nutrition and vitamin-D status
• Medication and other medical factors affecting bone healing
• Compliance with postoperative restrictions

Who May Be a Candidate for InSpan?

InSpan may be considered when symptoms, examination, and imaging identify a focal level where direct decompression and supplemental posterior fixation are clinically appropriate. Possible features include:

• Lumbar spinal stenosis producing neurogenic claudication or radicular symptoms
• Selected low-grade degenerative spondylolisthesis or another carefully assessed instability pattern
• A planned decompression that may require additional posterior stabilization
• Selected degenerative disc disease when the painful level and fusion indication are supported by the complete evaluation
• Adequate spinous-process anatomy and bone quality
• Symptoms that remain function-limiting despite appropriate conservative treatment

The presence of stenosis alone does not establish the need for fusion. When a stable segment can be adequately treated with decompression alone, adding a fusion construct may provide no meaningful advantage.

Who May Not Be a Good Candidate?

InSpan may not be appropriate when there is:

• Severe osteoporosis or inadequate posterior-element strength
• A fractured, absent, or surgically compromised spinous process at the intended level
• High-grade spondylolisthesis, major instability, or deformity requiring a stronger or broader construct
• Severe multilevel disease that cannot be addressed through a focal approach
• Extensive fixed stenosis requiring wider decompression than can safely be combined with this construct
• Active infection, untreated tumor, acute fracture, or another condition requiring a different operation
• Symptoms that do not match the proposed spinal level
• A clinical situation in which decompression alone is sufficient

Evaluation Before the InSpan Procedure

The preoperative evaluation should determine both what is compressing the nerves and whether stabilization is actually needed. It may include:

• History and neurological examination: to separate neurogenic claudication or radiculopathy from hip disease, peripheral neuropathy, vascular claudication, and other pain generators.
• Lumbar MRI: to identify ligamentum flavum hypertrophy, facet overgrowth, central or lateral-recess stenosis, foraminal narrowing, and nerve-root compression.
• Standing and flexion-extension X-rays: when alignment or dynamic instability is suspected.
• CT imaging: selectively, when posterior-element anatomy or prior surgery needs further definition.
• Bone-health assessment: when age, fracture history, medication exposure, or other factors raise concern for osteoporosis.
• Review of conservative care: including rehabilitation, medication, injections, and activity modification when appropriate.

How Is the InSpan Procedure Performed?

The exact procedure depends on the stenosis pattern, the decompression required, the supporting fusion construct, and the patient’s anatomy.

When Might FacetFuse or Other Supplemental Fixation Be Considered?

InSpan and FacetFuse engage different posterior pathways. InSpan engages the spinous-process region. FacetFuse uses the facet-joint pathway. Neither should be added merely to place more hardware.

The FDA labeling identifies InSpan as a supplemental fixation system and states that it is not intended for stand-alone use. The complete supporting construct must therefore follow the device labeling and the individual surgical plan. Additional fixation may be considered when factors such as instability, facet degeneration, rotational control, decompression-related loss of support, or another mechanical concern require it.

Pedicle-screw fixation remains appropriate when more powerful multidirectional stabilization or a broader fusion construct is required.

Potential Benefits of an InSpan-Based Strategy

For appropriately selected patients, potential advantages may include:

• A focused posterior midline approach
• The ability to perform limited direct decompression before fixation
• Less lateral muscle disruption than many traditional pedicle-screw constructs
• Posterior fixation with bone-graft-supported fusion
• Outpatient treatment in carefully selected patients
• A potential middle ground between decompression alone and a larger conventional fusion

These potential advantages do not establish that InSpan is superior to another fixation system. There are no strong head-to-head trials showing that InSpan produces better outcomes than Minuteman, pedicle-screw fusion, or another device across comparable patients.

Risks and Limitations

Possible risks include:

• Bleeding, infection, wound complications, or anesthesia-related problems
• Dural tear or spinal-fluid leak during decompression
• Nerve irritation, new numbness or weakness, or rare nerve injury
• Incomplete decompression or persistent stenosis symptoms
• Spinous-process or posterior-element fracture
• Implant malposition, loosening, migration, or breakage
• Nonunion or pseudarthrosis
• Persistent or recurrent back or leg pain
• Adjacent-level degeneration over time
• Need for revision decompression or a larger fusion construct
• Additional hardware-related risks when another fixation system is used

What Does the Evidence Show?

The FDA summary cites a retrospective review of prospectively collected data involving 56 patients treated for degenerative disc disease with lumbar spinal stenosis. The study reported statistically significant improvement in back-pain and disability measures at 24 months.

A related 2020 publication reported follow-up beyond five years in a selected outpatient L4-L5 cohort. Those findings are encouraging, but they come from a small, highly selected experience rather than a large randomized comparison.

The limitations matter:

• Most published InSpan evidence consists of observational or retrospective data.
• The samples are small and frequently involve selected single-level cases.
• Device-specific evidence does not establish superiority over other fixation systems.
• Evidence supporting fusion in lumbar stenosis does not mean that every stenosis patient benefits from fusion.

A 2025 systematic review found limited benefit from routinely adding fusion to decompression in lumbar stenosis patients without spondylolisthesis or instability. This reinforces the need to establish a real mechanical indication rather than adding fixation automatically.

How Does InSpan Compare With Other Lumbar Procedures?

This table describes procedural categories rather than ranking manufacturers. Device selection must follow the diagnosis, anatomy, FDA labeling, supporting construct, and surgeon’s technical plan.

Recovery After InSpan

Many selected patients can go home the same day after appropriate monitoring. Recovery depends on how much decompression was performed, the complete fixation construct, medical health, job demands, and postoperative symptoms.

General recovery considerations may include:

• Early walking with individualized activity limits
• Temporary incisional and muscular soreness
• Restrictions on heavy lifting, repetitive bending, twisting, and strenuous activity while fusion develops
• Wound and neurological follow-up
• Gradual return to work according to job demands
• Rehabilitation when appropriate
• Follow-up imaging to evaluate alignment, hardware, and fusion progress when clinically indicated

Nerve symptoms may improve before the fusion matures. Immediate pain relief does not prove fusion, and early soreness does not necessarily mean the operation has failed.

Does Insurance Cover InSpan?

Coverage varies by insurer, diagnosis, benefit plan, documented conservative care, fusion criteria, and the payer’s policy on interspinous fixation devices. FDA clearance does not guarantee payment. Some insurers consider interspinous fixation investigational or restrict coverage to narrowly defined circumstances.

The office should verify authorization, the planned decompression and supporting fusion construct, and the patient’s anticipated financial responsibility before scheduling. Authorization does not guarantee final payment.

Key Takeaways

• InSpan is a supplemental fixation and fusion device, not simply a distraction spacer.
• Its FDA labeling requires bone graft and states that it is not intended for stand-alone use.
• The posterior approach can permit focused direct removal of compressive ligament or bone.
• The decompression is performed by the surgeon; it is not an inherent action of the implant.
• InSpan does not replace pedicle-screw fusion in complex instability or deformity.
• Not every patient with spinal stenosis needs fusion.
• Bone quality, posterior-element integrity, and the complete supporting construct are essential.
• There is no strong evidence that InSpan is universally superior to another fixation device.
• The correct question is whether the complete decompression-and-stabilization plan solves the patient’s actual problem.

Frequently Asked Questions About InSpan

References and Related Resources

1. U.S. Food and Drug Administration. 510(k) K213266: InSpan ScrewLES Fusion System. Decision date December 3, 2021.
2. Chin KR, et al. Greater than five-year follow-up of outpatient L4-L5 lumbar interspinous fixation for degenerative spinal stenosis using the InSpan device. Journal of Spine Surgery. 2020.
3. Tsuang FY, et al. Long-term reoperation after decompression with versus without fusion among patients with degenerative lumbar spinal stenosis: systematic review and meta-analysis. The Spine Journal. 2025.

Related internal guides:

• Minimally Invasive Lumbar Decompression
• Endoscopic Lumbar Decompression
• MILD Procedure
• Minuteman Procedure
• Minimally Invasive Spinal Fusion
• FacetFuse
• Lumbar Spinal Stenosis